Stimuli-responsive antioxidant nanoprodrugs of NSAIDs

International Journal of Pharmaceutics

Volumn 372, Issue 1-2, 2009, Pages 112-124

  Lee, Bong Seop ^a   Yuan, Xiangpeng ^a   Xu, Qijin ^a   McLafferty, Fred S ^a   Petersen, Brian A ^a   Collette, Jeremy C ^a   Black, Keith L ^a   Yu, John S ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Antioxidant; Nanoprodrugs; NSAIDs; Oxidative destabilization; Prodrugs; Stimuli responsive

Indexed keywords

ESTERASE; HYPOCHLOROUS ACID; IBUPROFEN; INDOMETACIN; LIVER ENZYME; NAPROXEN; PRODRUG; THIOCTIC ACID;

ANTIOXIDANT ACTIVITY; ARTICLE; DRUG ACTIVATION; DRUG HYDROLYSIS; DRUG OXIDATION; DRUG RELEASE; DRUG SYNTHESIS; EMULSION; ENZYME MECHANISM; IN VITRO STUDY; PARTICLE SIZE; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; NANOTECHNOLOGY; PARTICLE SIZE; PRODRUGS; SWINE;

EID: 64149103694     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.12.037     Document Type: Article

References (59)

1. Asensio C., Levoin N., Guillaume C., Guerquin M.J., Rouguieg K., Chrétien F., Chapleur Y., Netter P., Minn A., and Lapicque F. Irreversible inhibition of glucose-6-phosphate dehydrogenase by the conenzyme A conjugate of ketoprofen: a key to oxidative stress induced by non-steroidal anti-inflammatory drugs?. Biochem. Pharmacol. 73 (2007) 405-416
2. Babior B.M. Phagocytes and oxidative stress. Am. J. Med. 109 (2000) 33-44
3. Basivireddy J., Jacob M., Pulimood A.B., and Balasubramanian K.A. Indomethacin-induced renal damage: role of oxygen free radicals. Biochem. Pharmacol. 67 (2004) 587-599
4. Bellomo E.G., Wyrsta M.D., Pakstis L., Pochan D.J., and Deming T.J. Stimuli-responsive polypeptide vesicles by conformation-specific assembly. Nat. Mater. 3 (2004) 244-248
5. Biewenga G.Ph., de Jong J., and Bast A. Lipoic acid favors thiosulfinate formation after hypochlorous acid scavenging: a study with lipoic acid derivatives. Arch. Biochem. Biophys. 312 (1994) 114-120
6. Biewenga G.Ph., Haenen G.R.M.M., and Bast A. The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 29 (1997) 315-331
7. Bonina F.P., Montenegro L., de Caprariis P., Palagiano F., Capasso A., and Sorrentino L. Pharmacokinetic and pharmacodynamic profile of triethylene glycol indomethacin ester as a new oral prodrug. J. Control. Release 41 (1996) 187-193
8. Bonina F.P., Puglia C., Barbuzzi T., de Caprariis P., Palagiano F., Rimoli M.G., and Saija A. In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac. Eur. J. Pharm. Sci. 14 (2001) 123-134
9. Bouchemal K., Briancon S., Perrier E., Fessi H., Bonnet I., and Zydowicz N. Synthesis and characterization of polyurethane and poly(ether urethane) nanocapsules using a new technique of interfacial polycondensation combined to spontaneous emulsification. Int. J. Pharm. 269 (2004) 89-100
10. Bouchemal K., Briancon S., Perrier E., and Fessi H. Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation. Int. J. Pharm. 280 (2004) 241-251
11. Bundgaard H., and Nielsen N.M. Glycolamide esters as a biolabile prodrug type for non-steroidal anti-inflammatory carboxylic acid drugs. Int. J. Pharm. 43 (1988) 101-110
12. Candeias L.P., Patel K.B., Stratford M.R.L., and Wardman P. Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid. FEBS Lett. 333 (1993) 151-153
13. Carafa M., Marianecci C., Annibaldi V., Di Stefano A., Sozio P., and Santucci E. Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: development, characterization and interaction with leuprolide. Int. J. Pharm. 325 (2006) 155-162
14. Chandrasekaran S., Al-Ghananeem A.M., Riggs R.M., and Crooks P. Synthesis and stability of two indomethacin prodrugs. Bioorg. Med. Chem. Lett. 16 (2006) 1874-1879
15. Ching T.L., de Jong J., and Bast A. A method for screening hypochlorous acid scavengers by inhibition of the oxidation of 5-thio-2-nitrobenzoic acid. Application to antiastmatic drugs. Anal. Biochem. 218 (1994) 377-381
16. Chouinard F., Kan F.W., Leroux J.C., Foucher C., and Lanaert V. Preparation and purification of polyisohexylcyanoacrylate nanocapsules. Int. J. Pharm. 72 (1991) 211-217
17. Dannhardt G., and Kiefer W. Cyclooxygenase inhibitors-current status and future prospects. Eur. J. Med. Chem. 36 (2001) 109-126
18. Detsi A., Bouloumbasi D., Prousis K.C., Koufaki M., Athanasellis G., Melagraki G., Afantitis A., Igglessi-Markopoulou O., Kontogiorgis C., and Hadjipavlou-Litina D.J. Design and synthesis of novel quinolinone-3-aminoamides and their α-lipoic acid adducts as antioxidant and anti-inflammatory agents. J. Med. Chem. 50 (2007) 2450-2458
19. Fattal E., Couvreur P., and Dubernet C. "Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes. Adv. Drug Deliv. Rev. 56 (2004) 931-946
20. Fessi H., Puisieux F., Devissaguet J.Ph., Ammoury N., and Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55 (1989) R1-R4
21. Finkei T., and Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000) 239-247
22. Foote C.S., Goyne T.E., and Lehrer R.I. Assessment of chlorination by human neutrophils. Nature 301 (1983) 715-716
23. Foroutan S.M., and Watson D.G. The in vitro evaluation of polyethylene glycol esters of hydrocortisone 21-succinate as ocular prodrugs. Int. J. Pharm. 182 (1999) 79-92
24. Friedrich B., Jung K., Lein M., Türk I., Rudolph B., Hampel G., Schnorr D., and Loening S.L. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. Eur. J. Cancer 35 (1999) 138-144
25. Hafkenscheid T.L., and Tomlinson E. Relationships between hydrophobic (lipophilic) properties of bases and their retention in reversed-phase liquid chromatography using aqueous methanol mobile phases. J. Chromatogr. 292 (1984) 305-317
26. Hammers W.E., Meurs G.J., and De Ligny C.L. Correlations between liquid chromatographic capacity ratio data on lichrosorb RP-18 and partition coefficients in the octanol-water system. J. Chromatogr. 247 (1982) 1-13
27. Hansch C., and Elkins D. Partition coefficients and their uses. Chem. Rev. 71 (1971) 525-554
28. Hassan A., Martin E., and Puig-Parellada P. Role of antioxidants in gastric mucosal damage induced by indomethacin in rats. Methods Find. Exp. Clin. Pharmacol. 20 (1998) 849-854
29. Heckert E.G., Karakoti A.S., Seal S., and Self W.T. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials 29 (2008) 2705-2709
30. Huang B., Zhang J., Hou J., and Chen C. Free radical scavenging efficiency of nano-Se in vitro. Free Radic. Biol. Med. 35 (2003) 805-813
31. Hussien M., Delecata R.J., and Carey P.D. Neutrophil hypochlorous acid production is impaired in multiple organ failure patients with candidaemia; reversal with antifungal agents. Inflamm. Res. 51 (2002) 213-217
32. Iley J., Moreira R., Calheiros T., and Mendes E. Acyloxymethyl as a drug protecting group. Part 4. The hydrolysis of tertiary amidomethyl ester prodrugs of carboxylic acid agents. Pharm. Res. 14 (1997) 1634-1639
33. Ineu R.P., Pereira M.E., Aschner M., Nogueira C.W., Zeni G., and Rocha J.B.T. Diphenyl diselenide reverses gastric lesions in rats: involvement of oxidative stress. Food Chem. Toxicol. 46 (2008) 3023-3029
34. Kourounakis P.N., Tsiakitzis K., Kourounakis A.P., and Galanakis D. Reduction of gastrointestinal toxicity of NSAIDs via molecular modifications leading to antioxidant anti-inflammatory drugs. Toxicology 144 (2000) 205-210
35. Krasowska A., and Konat G.W. Vulnerability of brain tissue to inflammatory oxidant, hypochlorous acid. Brain Res. 997 (2004) 176-184
36. Kusuhara H., Komatsu H., Sumichika H., and Sugahara K. Reactive oxygen species are involved in the apoptosis induced by nonsteroidal anti-inflammatory drugs in cultured gastric cells. Eur. J. Pharmacol. 383 (1999) 331-337
37. Malle E., Furtmüller P.G., Sattler W., and Obinger C. Myeloperoxidase: a target for new drug development?. Br. J. Pharmacol. (2007) 1-17
38. McKenzie D.L., Kwok K.Y., and Rice K.G. A potent new class of reductively activated peptide gene delivery agents. J. Biol. Chem. 275 (2000) 9970-9977
39. Mendes E., Furtado T., Neres J., Iley J., Jarvinen T., Rautio J., and Moreira R. Synthesis, stability and in vitro dermal evaluation of aminocarbonyloxymethyl esters as prodrugs of carboxylic acid agents. Bioorg. Med. Chem. 10 (2002) 809-816
40. Messner M.C., Albert C.J., Hsu F.F., and Ford D.A. Selective plasmenylcholine oxidation by hypochlorous acid: formation of lysophosphatidylcholine chlorohydrins. Chem. Phys. Lipids 144 (2006) 34-44
41. Morris C.J. The acid ionization constant of HOCl from 5 to 35 °C. J. Phys. Chem. 70 (1966) 3798-3805
42. Napoli A., Valentini M., Tirelli N., Müller M., and Hubbell J.A. Oxidation responsive polymeric vesicles. Nat. Mater. 3 (2004) 183-189
43. Packer L., Witt E.H., and Tritschler H.J. Alpha-lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 19 (1995) 227-250
44. Rautio J., Kumpulainen H., Heimbach T., Oliyai R., Oh D., Järvinen T., and Savolainen J. Prodrugs: design and clinical applications. Nat. Rev. Drug Discov. 7 (2008) 255-270
45. Redden P.R., Melanson R.L., Douglas J.A.E., and Dick A.J. Acyloxymethyl acidic drug derivatives: in vitro hydrolytic reactivity. Int. J. Pharm. 180 (1999) 151-160
46. Riddles P.W., Blakeley R.L., and Zerner B. Reassessment of Ellman's reagent. Methods Enzymol. 91 (1983) 49-60
47. Rodrigues P.C.A., Scheuermann K., Stockmar C., Maier G., Fiebig H.H., Unger C., Mülhaupt R., and Kratza F. Synthesis and in vitro efficacy of acid-sensitive poly(ethylene glycol) paclitaxel conjugates. Bioorg. Med. Chem. Lett. 13 (2003) 355-360
48. Siskou I.C., Rekka E.A., Kourounakis A.P., Chrysselis M.C., Tsiakitzis K., and Kourounakis P.N. Design and study of some novel ibuprofen derivatives with potential nootropic and neuroprotective properties. Bioorg. Med. Chem. 15 (2007) 951-961
49. Spickett C.M. Chlorinated lipids and fatty acids: an emerging role in pathology. Pharmacol. Ther. 115 (2007) 400-409
50. Tammara V.K., Narurkar M.M., Crider A.M., and Khan A.M. Synthesis and evaluation of morpholinoalkyl ester prodrugs of indomethacin and naproxen. Pharm. Res. 10 (1993) 1191-1199
51. Trujillo M., and Radi R. Peroxynitrite reaction with the reduced and the oxidized forms of lipoic acid: new insights into the reaction of peroxynitrite with thiols. Arch. Biochem. Biophys. 397 (2002) 91-98
52. Ulbrich K., and Šubr V. Polymeric anticancer drugs with pH-controlled activation. Adv. Drug Deliv. Rev. 56 (2004) 1023-1050
53. 2-acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO-NSAIDs): synthesis, nitric oxide release, and biological evaluation studies. Bioorg. Med. Chem. 15 (2007) 4767-4774
54. Wagner A.F., Walton E., Boxer G.E., Pruss M.P., Holly F.W., and Folkers K. Properties and derivatives of α-lipoic acid. J. Am. Chem. Soc. 78 (1956) 5079-5081
55. Weiss S.J., Klein R., Slivka A., and Wei M. Chlorination of taurine by human neutrophils: evidence for hypochlorous acid generation. J. Clin. Invest. 70 (1982) 598-607
56. Whittle B.J.R. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Fundam. Clin. Pharmacol. 17 (2003) 301-313
57. Winterbourn C.C. Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology 181-182 (2002) 223-227
58. Yap Y.W., Whiteman M., and Cheung N.S. Chlorinative stress: an under appreciated mediator of neurodegeneration?. Cell. Signal. 19 (2007) 219-228
59. Zhao X., Tao X., Wei D., and Song Q. Pharmacological activity and hydrolysis behavior of novel ibuprofen glucopyranoside conjugates. Eur. J. Med. Chem. 41 (2006) 1352-1358